Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q2 EPS of ($0.13), $0.09 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.